Poseida Lands $23,033,232 New Funding

  • Feed Type
  • Date
    12/28/2015
  • Company Name
    Poseida
  • Mailing Address
    4250 Executive Square La Jolla, CA 92037 USA
  • Company Description
    Poseida Therapeutics is a spin out of Transposagen Biopharmaceuticals that utilizes best-in-class, proprietary genome editing technologies to develop targeted, life-saving therapeutics in areas of high unmet medical need.
  • Website
    http://www.poseida.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $23,033,232
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy